These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 15980359)

  • 1. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37.
    Ciornei CD; Sigurdardóttir T; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2845-50. PubMed ID: 15980359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of the lipopolysaccharide-neutralizing activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by replacement with hydrophobic and cationic amino acid residues.
    Nagaoka I; Hirota S; Niyonsaba F; Hirata M; Adachi Y; Tamura H; Tanaka S; Heumann D
    Clin Diagn Lab Immunol; 2002 Sep; 9(5):972-82. PubMed ID: 12204946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico identification and biological evaluation of antimicrobial peptides based on human cathelicidin LL-37.
    Sigurdardottir T; Andersson P; Davoudi M; Malmsten M; Schmidtchen A; Bodelsson M
    Antimicrob Agents Chemother; 2006 Sep; 50(9):2983-9. PubMed ID: 16940092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short KR-12 analogs designed from human cathelicidin LL-37 possessing both antimicrobial and antiendotoxic activities without mammalian cell toxicity.
    Jacob B; Park IS; Bang JK; Shin SY
    J Pept Sci; 2013 Nov; 19(11):700-7. PubMed ID: 24105706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
    Nan YH; Bang JK; Jacob B; Park IS; Shin SY
    Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Augmentation of the bactericidal activities of human cathelicidin CAP18/LL-37-derived antimicrobial peptides by amino acid substitutions.
    Nagaoka I; Kuwahara-Arai K; Tamura H; Hiramatsu K; Hirata M
    Inflamm Res; 2005 Feb; 54(2):66-73. PubMed ID: 15750713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Titanium surfaces immobilized with the major antimicrobial fragment FK-16 of human cathelicidin LL-37 are potent against multiple antibiotic-resistant bacteria.
    Mishra B; Wang G
    Biofouling; 2017 Aug; 33(7):544-555. PubMed ID: 28675109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipopolysaccharide Phosphorylation by the WaaY Kinase Affects the Susceptibility of Escherichia coli to the Human Antimicrobial Peptide LL-37.
    Bociek K; Ferluga S; Mardirossian M; Benincasa M; Tossi A; Gennaro R; Scocchi M
    J Biol Chem; 2015 Aug; 290(32):19933-41. PubMed ID: 26100635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antimicrobial peptides derived from human cathelicidin LL-37 on Entamoeba histolytica trophozoites.
    Rico-Mata R; De Leon-Rodriguez LM; Avila EE
    Exp Parasitol; 2013 Mar; 133(3):300-6. PubMed ID: 23274811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and function of a potent lipopolysaccharide-binding antimicrobial and anti-inflammatory peptide.
    Wei L; Yang J; He X; Mo G; Hong J; Yan X; Lin D; Lai R
    J Med Chem; 2013 May; 56(9):3546-56. PubMed ID: 23594231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RL-37, an alpha-helical antimicrobial peptide of the rhesus monkey.
    Zhao C; Nguyen T; Boo LM; Hong T; Espiritu C; Orlov D; Wang W; Waring A; Lehrer RI
    Antimicrob Agents Chemother; 2001 Oct; 45(10):2695-702. PubMed ID: 11557457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of human cathelicidin antimicrobial peptide LL-37 on lipopolysaccharide-induced nitric oxide release from rat aorta in vitro.
    Ciornei CD; Egesten A; Bodelsson M
    Acta Anaesthesiol Scand; 2003 Feb; 47(2):213-20. PubMed ID: 12631052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LL-37-derived short antimicrobial peptide KR-12-a5 and its d-amino acid substituted analogs with cell selectivity, anti-biofilm activity, synergistic effect with conventional antibiotics, and anti-inflammatory activity.
    Kim EY; Rajasekaran G; Shin SY
    Eur J Med Chem; 2017 Aug; 136():428-441. PubMed ID: 28525841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel, rationally designed, hybrid antimicrobial peptide, inspired by cathelicidin and aurein, exhibits membrane-active mechanisms against Pseudomonas aeruginosa.
    Klubthawee N; Adisakwattana P; Hanpithakpong W; Somsri S; Aunpad R
    Sci Rep; 2020 Jun; 10(1):9117. PubMed ID: 32499514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils.
    Turner J; Cho Y; Dinh NN; Waring AJ; Lehrer RI
    Antimicrob Agents Chemother; 1998 Sep; 42(9):2206-14. PubMed ID: 9736536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cationic antimicrobial peptides: alternatives and/or adjuvants to antibiotics active against methicillin-resistant Staphylococcus aureus and multidrug-resistant Pseudomonas aeruginosa.
    Geitani R; Ayoub Moubareck C; Touqui L; Karam Sarkis D
    BMC Microbiol; 2019 Mar; 19(1):54. PubMed ID: 30849936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alanine and Lysine Scans of the LL-37-Derived Peptide Fragment KR-12 Reveal Key Residues for Antimicrobial Activity.
    Gunasekera S; Muhammad T; Strömstedt AA; Rosengren KJ; Göransson U
    Chembiochem; 2018 May; 19(9):931-939. PubMed ID: 29430821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-quality 3D structures shine light on antibacterial, anti-biofilm and antiviral activities of human cathelicidin LL-37 and its fragments.
    Wang G; Mishra B; Epand RF; Epand RM
    Biochim Biophys Acta; 2014 Sep; 1838(9):2160-72. PubMed ID: 24463069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships among human cathelicidin peptides: dissociation of antimicrobial properties from host immunostimulatory activities.
    Braff MH; Hawkins MA; Di Nardo A; Lopez-Garcia B; Howell MD; Wong C; Lin K; Streib JE; Dorschner R; Leung DY; Gallo RL
    J Immunol; 2005 Apr; 174(7):4271-8. PubMed ID: 15778390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial Activities of LL-37 Fragment Mutant-Poly (Lactic-Co-Glycolic) Acid Conjugate against
    Mori T; Yoshida M; Hazekawa M; Ishibashi D; Hatanaka Y; Nagao T; Kakehashi R; Kojima H; Uno R; Ozeki M; Kawasaki I; Yamashita T; Nishikawa J; Uchida T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.